Loading data
LITENasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 3.01 bn USD | 1.65 bn USD | 1.36 bn USD | 1.77 bn USD | 1.71 bn USD |
| Gross profit | 1.26 bn USD | 459.9 m USD | 251.5 m USD | 569 m USD | 788.6 m USD |
| Research and development expense | 356.5 m USD | 303.9 m USD | 302.2 m USD | 307.8 m USD | 220.7 m USD |
| Selling, general and administrative expense | 363.2 m USD | 348.2 m USD | 310.7 m USD | 348.8 m USD | 265.7 m USD |
| Operating profit | 524.8 m USD | -180.1 m USD | -434 m USD | -115.7 m USD | 303.3 m USD |
| Interest expense | — | — | — | 35.5 m USD | 80.2 m USD |
| Income tax expense | -237.7 m USD | -198 m USD | 140.8 m USD | 29.2 m USD | 36.2 m USD |
| Net income (reported basis) | -6.94 bn USD | 25.9 m USD | -546.5 m USD | -131.6 m USD | 198.9 m USD |
| Net income attributable to common shareholders | — | 25.9 m USD | -546.5 m USD | -131.6 m USD | 198.9 m USD |
| Basic earnings per share | -92.96 USD/share | 0.38 USD/share | -8.12 USD/share | -1.93 USD/share | 2.79 USD/share |
| Diluted earnings per share | -92.96 USD/share | 0.37 USD/share | -8.12 USD/share | -1.93 USD/share | 2.68 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.